相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations
Laurent Kodjikian et al.
EYE (2021)
Automated Quantification of Pathological Fluids in Neovascular Age-Related Macular Degeneration, and Its Repeatability Using Deep Learning
Irmela Mantel et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Results From LUMINOUS, a Global Real-World Study
Frank G. Holz et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2020)
ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD)
Sandra Liakopoulos et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age-related macular degeneration
Usha Chakravarthy et al.
EYE (2020)
Automatically Enhanced OCT Scans of the Retina: A proof of concept study
Stefanos Apostolopoulos et al.
SCIENTIFIC REPORTS (2020)
Developing a delivery science for artificial intelligence in healthcare
Ron C. Li et al.
NPJ DIGITAL MEDICINE (2020)
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension
Samantha Cruz Rivera et al.
LANCET DIGITAL HEALTH (2020)
Expert-level Automated Biomarker Identification in Optical Coherence Tomography Scans
Thomas Kurmann et al.
SCIENTIFIC REPORTS (2019)
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
Josep Callizo et al.
CLINICAL OPHTHALMOLOGY (2019)
Fused Detection of Retinal Biomarkers in OCT Volumes
Thomas Kurmann et al.
MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION - MICCAI 2019, PT I (2019)
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
Saira Khanna et al.
BMJ OPEN OPHTHALMOLOGY (2019)
Artificial intelligence in healthcare
Kun-Hsing Yu et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration
Rehan M. Hussain et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Analyzing and Predicting Visual Acuity Outcomes of Anti-VEGF Therapy by a Longitudinal Mixed Effects Model of Imaging and Clinical Data
Wolf-Dieter Vogl et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
Deep Learning Is Effective for Classifying Normal versus Age-Related Macular Degeneration OCT Images
Cecilia S. Lee et al.
OPHTHALMOLOGY RETINA (2017)
Prediction of Anti-VEGF Treatment Requirements in Neovascular AMD Using a Machine Learning Approach
Hrvoje Bogunovic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2017)
A systematic review of as needed versus treat and extend ranibizumab or bevacizumab treatment regimens for neovascular age-related macular degeneration
David Chin-Yee et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2016)
Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study
Jonathan L. Prenner et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Frank G. Holz et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
Ursula Schmidt-Erfurth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Recent developments in the treatment of age-related macular degeneration
Frank G. Holz et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany
Robert P. Finger et al.
ACTA OPHTHALMOLOGICA (2013)
CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE The LUMIERE Study
Salomon Y. Cohen et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)